ABT · 10-Q · 2026Q3 · Full report
Interest Expense Increase
ABBOTT LABORATORIES · 2026-11-04 · Importance 76 · Surprise 82 · In source text
Net interest expense increased $253 million to $297 million in the third quarter of 2026. For the first nine months, it increased $521 million to $664 million. The increases primarily reflected interest on debt incurred to finance the Exact Sciences acquisition, including the $20.0 billion long-term debt issuance in March.
Key facts
- Abbott’s interest rate hedge contracts had a notional amount of $4.2 billion at September 30, 2026, compared with $1.2 billion at December 31, 2025; the increase reflected additional hedges associated with fixed-rate debt issued for the Exact Sciences acquisition. source
- Net interest expense increased $253 million to $297 million in the third quarter of 2026 and increased $521 million to $664 million in the first nine months of 2026, primarily due to debt incurred for the Exact Sciences acquisition. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | realized | -4.0% | Net interest expense increased $253 million to $297 million in the third quarter of 2026 and increased $521 million to $664 million in the… |